好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Vascular Risk Factors and Incident Epilepsy in Older Adults: A Pooled Cohort Analysis
Epilepsy/Clinical Neurophysiology (EEG)
P1 - Poster Session 1 (11:45 AM-12:45 PM)
9-006

To identify vascular risk factors (VRFs) for incident late-onset epilepsy (LOE) in older adults.

LOE (onset after age 65) is a common neurological disorder that may be associated with increased burden of VRFs.

We pooled individual participant data from five US cardiovascular cohorts: ARIC, CHS, MESA, NOMAS, and WHICAP. In ARIC, CHS, MESA, and WHICAP, we used Medicare claims to ascertain new-onset epilepsy occurring after the first 2 years of continuous Medicare enrollment using an algorithm based on ICD-9 or ICD-10 codes, and anti-seizure medications. In NOMAS, which was not linked to Medicare, we identified epilepsy using self-report, medical record review, and ICD-9 or ICD-10 codes in claims of the New York Statewide Planning and Research Cooperative System. D

Demographics were assessed by self-report, and VRFs by self-report, blood measures, EKG, physical exams, and medications.

Using individual participant meta-analysis with a fixed effect for cohort, we estimated the pooled cohort hazard ratios (HR) and 95% CI from multivariable Cox models. Participants were censored at death or end of continuous Medicare enrollment.

Among 28,291 participants with 294,575 person-years of follow-up, 998 developed LOE (3.39 per 1000 person-years).  Findings from Cox regression analysis suggested that LOE risk was higher for those age ≥85 (HR 2.23 95%CI [1.58, 3.15]) compared to 65-75 years, non-Hispanic [NH] Black (1.80 [1.56, 2.09]) and Hispanic (1.36 [1.09, 1.69]) compared to NH White participants, and those with current smoking (1.40 [1.23, 1.59]), hypertension (1.40 [1.23, 1.59]), diabetes (1.62 [1.38, 1.90]), eGFR<60 (1.35 [1.14, 1.59]), stroke (1.77 [1.29, 2.41]), heart disease (1.39 [1.16, 1.67]), and one (1.29 [1.11, 1.50]) or two APOE e4 alleles (2.12 [1.51, 2.99]) compared to none.

We identified VRFs that were independently associated with incident LOE. Potential mechanisms underlying the relationships between VRFs and LOE should be examined in future studies.

Authors/Disclosures
Evan Thacker, PhD (Brigham Young University)
PRESENTER
The institution of Evan Thacker, PhD has received research support from NIH.
Hyunmi Choi, MD (Columbia University Medical Center) Dr. Choi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Epilepsy Research by Elsevier. The institution of Dr. Choi has received research support from National Institute of Aging.
Jose Gutierrez, MD (Columbia University) Dr. Gutierrez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cardiovascular Research Foundation. Dr. Gutierrez has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for White and Rusell. Dr. Gutierrez has received research support from NIH. Dr. Gutierrez has received publishing royalties from a publication relating to health care. Dr. Gutierrez has received publishing royalties from a publication relating to health care.
Cheng-Shiun Leu, PhD Prof. Leu has nothing to disclose.
Tian Wang Dr. Wang has nothing to disclose.
Jiying Han, MS Miss Han has stock in Merck. Miss Han has stock in Eli Lilly. Miss Han has stock in Novo-Nordisk.
Sylwia Misiewicz, MA, EdM Mrs. Misiewicz has nothing to disclose.
Emily Johnson, MD (Johns Hopkins Epilepsy Center) Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EpiWatch. Dr. Johnson has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. The institution of Dr. Johnson has received research support from NIH.
W. T. Longstreth, Jr., MD, FAAN (Harborview Medical Center) The institution of Dr. Longstreth has received research support from NIH.
Mary Biggs, PhD The institution of Dr. Biggs has received research support from NIH.
Annette Fitzpatrick, PhD (University of Washington) No disclosure on file
Steven J. Shea, MD Dr. Shea has nothing to disclose.
Craig Johnson Mr. Johnson has nothing to disclose.
Mitchell S. Elkind, MD, MS, FAAN Dr. Elkind has received personal compensation for serving as an employee of American Heart Association. Dr. Elkind has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Atria Academy.
Tatjana Rundek, MD, PhD The institution of Dr. Rundek has received research support from NIH.
Kevin Strobino, MPH Mr. Strobino has nothing to disclose.
Lisandro D. Colantonio, MD, PhD The institution of Dr. Colantonio has received research support from Amgen.
Lei Huang, PhD Ms. Huang has nothing to disclose.
Carolyn C. ZHU Dr. ZHU has nothing to disclose.
Danurys Sanchez (Columbia University) Danurys Sanchez has nothing to disclose.
Dolly Reyes-Dumeyer (Columbia University) Dolly Reyes-Dumeyer has nothing to disclose.
Richard P. Mayeux, MD, MSc, FAAN (The Neurological Institute, Columbia University Medical Center) Dr. Mayeux has nothing to disclose.
Natalie Bello (Cedars-Sinai Medical Center) Natalie Bello has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CRF. The institution of Natalie Bello has received research support from NIH.
Deborah A. Levine (University of Michigan) No disclosure on file
Oluwadamilola R. Obalana Miss Obalana has nothing to disclose.
Stefany P. Diaz Andino, MPH Mrs. Diaz Andino has nothing to disclose.
Brian Petersen Mr. Petersen has nothing to disclose.
Sofia Maia Ms. Maia has nothing to disclose.